 Anika Therapeutics, Inc. ANIK, a global, integrated joint preservation and regenerative therapies company with products across the orthopedic early intervention continuum of care, today announced that Sylvia Cheung, Chief Financial Officer, has informed the Board of Directors of her decision, following a period of transition, to step away from her role at Anika effective August 21, 2020. Sylvia is an exemplary leader who has made many meaningful contributions to Anika over the years, said Cheryl R. Blanchard, Ph.D., President and Chief Executive Officer of Anika. 